ArticleDiabetes/metabolism research and reviews2026
Effectiveness and Safety of Once-Weekly Semaglutide 2.4 mg in Korean Adults With Obesity or Overweight: A Multicenter Retrospective Real-World Study (RE-SEMA-K Study).
Yu-Jin Kwon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.